Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dendritic cells (DCs) are professional antigen-presenting cells controlling the activation of T cells and thus regulating adaptive immune response against pathogens or tumors. Modeling human DC differentiation and function is crucial for our understanding of immune response and the development of new therapies. Considering DC rarity in human blood, in vitro systems allowing their faithful generation are needed. This chapter will describe a DC differentiation method based on the co-culture of CD34+ cord blood progenitors together with mesenchymal stromal cells (eMSCs) engineered to deliver growth factors and chemokines.

Original publication




Journal article


Methods Mol Biol

Publication Date





121 - 132


CD34, Conventional dendritic cells, Cord blood, Dendritic cells, Hematopoietic stem cells, In vitro differentiation, Mesenchymal stromal cells, Plasmacytoid dendritic cell, Humans, Dendritic Cells, Fetal Blood, Cells, Cultured, Antigens, CD34, Cell Differentiation, Cell Adhesion Molecules